Cook Medical Plans Rapid Scale-Up Of Newly Launched ENT Unit
This article was originally published in The Gray Sheet
Executive Summary
Firm unveils a range of new products for minimally invasive treatment of ear, nose and throat conditions Sept. 10 at the American Academy of Otolaryngology-Head and Neck Surgery annual conference in Washington, D.C.
You may also be interested in...
News Briefs: Panel OKs Sleep Apnea Stimulator; Two Stryker Buys; TAVR Updates
FDA panel unanimously endorses Inspire upper airway stimulator. Stryker buys Berchtold and Pivot. First randomized U.S. study of embolic protection during transcatheter aortic valve replacement approved. More news.
Ethicon Opens Up To Chronic Sinusitis Market With $785 Mil. Acclarent Buy
Johnson & Johnson/Ethicon will use its $785 million acquisition of Acclarent, developer of the Balloon Sinuplasty system for chronic sinusitis, as a platform for growth in the ear, nose and throat business
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.